Canine Heartworm Disease: Pathogenesis, Diagnosis, Prevention, and Treatment

Introduction

Canine heartworm disease is a potentially fatal parasitic infection caused by the filarial nematode Dirofilaria immitis. The disease is transmitted through the bite of an infected mosquito and affects canids globally, with increasing incidence in temperate and tropical regions [1, 2]. This article provides a clinical reference on the etiology, epidemiology, pathogenesis, diagnostic modalities, therapeutic protocols, and preventive strategies for D. immitis infection in dogs. The role of integrated parasite management, including dog heartworm and tick medicine, is examined within the context of macrocyclic lactone resistance and vector control.

Etiology and Life Cycle

Dirofilaria immitis belongs to the family Onchocercidae and the order Rhabditida [3]. Adult worms reside within the pulmonary arteries and right ventricle of the definitive host, where they cause endothelial damage and vascular inflammation [4, 5]. Female worms release microfilariae into the bloodstream; these are ingested by mosquito vectors during a blood meal [6, 7]. Within the mosquito, microfilariae develop through two molts to the infective third-stage larva (L3) over a period of 10 to 14 days, depending on ambient temperature [8]. The L3 larvae are transmitted to a new canine host during subsequent feeding, where they migrate through subcutaneous tissues and undergo two additional molts to reach the pulmonary vasculature approximately 70 to 90 days post-infection [9, 10]. The prepatent period, defined as the time from infection to the appearance of circulating microfilariae, ranges from 6 to 7 months [11, 12].

The obligate intracellular bacterium Wolbachia pipientis plays a central role in the biology of D. immitis [1]. Wolbachia endosymbionts are required for normal embryogenesis, larval development, and adult worm survival [1, 13]. The release of Wolbachia surface proteins and lipopolysaccharides during worm death contributes substantially to the inflammatory reaction observed in the host [14, 15].

Epidemiology

Canine heartworm disease has a cosmopolitan distribution, with endemic foci reported in North America, South America, southern Europe, Asia, and Australia [2, 16, 17, 18]. Molecular characterization of isolates from Sri Lanka, Ecuador, Pakistan, and the Amazon basin reveals substantial genetic diversity and local adaptation [1, 7, 11, 17, 19]. The prevalence of D. immitis in domestic dogs varies widely; serological surveys in rural northern Peru report seroprevalence values exceeding 30% in some regions [20], while studies in Slovenia and Hungary document lower infection rates in areas with cooler climates [6, 18]. Wildlife reservoirs, including coyotes (Canis latrans), maintain transmission cycles in peridomestic environments [2, 18].

Climate change is a critical driver of heartworm distribution [8]. Warmer temperatures shorten the extrinsic incubation period within mosquito vectors, enabling transmission in previously non-endemic zones [8, 21]. Molecular mosquito surveillance programs have identified D. immitis DNA in multiple Culicidae species, confirming the importance of vector competence and abundance [6, 7, 3]. Recent reports from the island of Saipan and humid coastal zones of Brazil highlight the expansion of D. immitis to new geographical areas [16, 22].

Pathogenesis and Clinical Signs

The pathophysiology of canine heartworm disease is driven by the mechanical obstruction and inflammatory response elicited by adult worms in the pulmonary arteries and right heart [4, 5]. Endothelial damage leads to villous endarteritis, thrombosis, and pulmonary hypertension. The severity of disease correlates with worm burden, duration of infection, and host immune reactivity [4]. Kim et al. [4] demonstrated that clinicopathologic variables such as haptoglobin concentration, plasma protein levels, and neutrophil counts are significantly associated with disease severity. Microfilaremic dogs exhibit elevated haptoglobin levels compared to amicrofilaremic infected dogs, indicating a differential acute-phase response [23].

Clinical signs progress from an asymptomatic state to cough, exercise intolerance, dyspnea, syncope, and right-sided congestive heart failure (caval syndrome) [5, 15]. Gastric dilatation and volvulus has been reported in a dog with situs inversus and concurrent heartworm disease, although this association may be incidental [5]. In rare cases, adult worms migrate aberrantly to the bronchial lumen, causing hemoptysis and bronchial obstruction [15]. Feline heartworm disease, though less common, presents with more acute respiratory signs and diagnostic challenges [24].

Diagnosis

Accurate diagnosis of canine heartworm disease requires a combination of antigen testing, microscopic examination for microfilariae, and advanced imaging. Each method has a specific window of detection and inherent limitations.

Antigen Testing

Commercial enzyme-linked immunosorbent assays (ELISAs) detect circulating adult D. immitis antigen, primarily from reproductively active female worms [25]. Point-of-care antigen tests are widely used for routine screening and demonstrate high specificity, but sensitivity may be reduced in low-burden infections or when only male worms are present [25]. Atkinson et al. [25] utilized Bayesian latent class modeling to evaluate the relative accuracy of point-of-care tests in clinically suspected dogs, reporting moderate sensitivity and high specificity. Novel point-of-care devices employing fluorescence or digital readout are under evaluation [26].

Microscopic and Molecular Detection

The modified Knott's test remains a standard method for identifying microfilariae and differentiating D. immitis from the non-pathogenic Dipetalonema reconditum [26, 27]. Molecular techniques, including conventional PCR, loop-mediated isothermal amplification (LAMP), and droplet digital PCR, offer enhanced sensitivity and species specificity [28, 29]. Genc et al. [28] developed a COI-LAMP assay with high sensitivity and specificity for D. immitis detection, particularly useful in epidemiological surveys. Quadruplex droplet digital PCR assays targeting single nucleotide polymorphisms associated with macrocyclic lactone resistance enable concurrent detection of resistance markers and parasite DNA [29].

Imaging

Thoracic radiography and echocardiography allow assessment of pulmonary arterial enlargement, right ventricular hypertrophy, and the presence of worm bundles [4, 5]. Echocardiography is particularly valuable in non-microfilaremic infections and in feline patients [24]. Computed tomography may be used for advanced staging in complicated cases [5].

Treatment

The goal of adulticidal therapy is to eliminate adult worms while minimizing thromboembolic complications. Traditional arsenical protocols using melarsomine dihydrochloride remain the standard of care in many settings, but non-arsenical alternatives are increasingly employed [13, 14, 15].

Macrocyclic Lactone-Based Protocols

Slow-kill protocols using moxidectin combined with doxycycline target Wolbachia endosymbionts, thereby reducing adult worm viability and microfilarial production [13, 15]. Santiwattanatarm et al. [13] performed a systematic review and meta-analysis of non-arsenical adulticide protocols and concluded that monthly moxidectin combined with doxycycline for 30 days is associated with reduced worm burden and lower risk of thromboembolism. The mechanism involves disruption of Wolbachia-dependent embryogenesis and a gradual reduction in worm antigenicity [1, 14]. A rare case of adult worm expulsion through bronchial mucus following this protocol has been documented [15].

Arsenical Therapy

Melarsomine is administered intramuscularly in a two-injection or three-injection series. Pretreatment with a macrocyclic lactone and doxycycline is recommended to decrease worm mass and mitigate post-adulticide thromboembolism [13, 14]. Geary [14] reviewed current chemotherapy issues, emphasizing the need for careful patient stratification based on disease severity. Treatment is contraindicated in cases of caval syndrome without surgical intervention.

Surgical Intervention

In caval syndrome, where adult worms cause mechanical obstruction of the tricuspid valve, emergency extraction via jugular venotomy or fluoroscopic-guided retrieval is indicated [5].

Prevention and Control

Prevention of canine heartworm disease relies on continuous administration of macrocyclic lactone anthelmintics (ivermectin, moxidectin, selamectin) at monthly intervals during the mosquito season or year-round in endemic areas [30, 31, 32]. Sustained-release injectable formulations provide extended protection for up to six months in some regions [30]. Combination products that also control fleas and ticks are widely used; these formulations constitute the category of dog heartworm and tick medicine, delivering both endectocidal and ectoparasiticidal activity [31, 32, 33]. Rodriguez et al. [31] demonstrated that a sarolaner/moxidectin/pyrantel combination is effective against a macrocyclic lactone-resistant D. immitis isolate, highlighting the utility of multi-modal prevention. Young et al. [32] reported high efficacy of a lotilaner/moxidectin/praziquantel/pyrantel chewable tablet in preventing heartworm infection. Martinez-Duran et al. [33] documented the prevalence of vector-borne pathogens in Spanish greyhounds and emphasized the need for sustained prophylaxis.

Macrocyclic Lactone Resistance

Resistance to macrocyclic lactones is an emerging threat, characterized by reduced efficacy of ivermectin and moxidectin in certain D. immitis isolates [31, 14, 29]. Molecular markers in the P-glycoprotein and glutamate-gated chloride channel genes have been identified, and droplet digital PCR assays can now detect these markers in field samples [29, 34]. Nichols and Forrester [34] characterized a novel glutamate-gated chloride channel subunit (GLC-2) from D. immitis, providing a potential target for novel anthelmintics.

Vector Control

Mosquito control measures, including habitat reduction, larvicides, and topical repellents, reduce the risk of exposure but cannot replace chemoprophylaxis [6, 3, 21]. Mosquito surveillance programs using molecular xenomonitoring help identify high-risk transmission zones [6, 3].

Diagnostic and Management Decision Tree

The following Mermaid diagram summarizes the clinical approach to a dog suspected of heartworm infection.

graph TD
    A[Dog suspected of heartworm disease], > B{Antigen test}
    B, >|Positive| C[Microfilaria test (Knott's or PCR)]
    B, >|Negative| D[Clinical signs or exposure risk?]
    D, >|Yes| E[Repeat antigen test in 3-4 months]
    D, >|No| F[No infection; continue prophylaxis]
    C, >|Microfilariae present| G[Confirm species differentiation]
    C, >|No microfilariae| H[Occult infection; proceed to imaging]
    G, >|D. immitis| I[Stage disease severity]
    G, >|D. reconditum| J[Treat if symptomatic; no heartworm therapy]
    H, > I
    I, > K[Echocardiography, thoracic radiography]
    K, > L{Disease severity}
    L, >|Class 1 or 2| M[Doxycycline + macrocyclic lactone x 30 days]
    L, >|Class 3 or 4| N[Melarsomine protocol + supportive care]
    M, > O[Repeat antigen test at 6 and 9 months]
    N, > O
    O, >|Antigen negative| P[Resolution; continue prevention]
    O, >|Antigen positive| Q[Re-treat or consider surgical extraction]

References

[1] Loku Gamage N, Ranasinghe K, Rodrigo W. Molecular Characterization of Wolbachia Endosymbionts and Their Association With Canine Dirofilariasis in Colombo District, Sri Lanka. J Parasitol Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42328691/

[2] Leaman LJ, Graham KF, Jones MEB, et al. First reported case of Dirofilaria immitis in a coyote (Canis latrans) from Prince Edward Island. Can Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/42266338/

[3] Hammond NG, Todaro A, Fairbanks KA, et al. Mosquito (Diptera: Culicidae) surveillance for Dirofilaria immitis (Rhabditida: Onchocercidae) using a zoo as a focus for operational detection in central Utah. J Med Entomol. 2026. https://pubmed.ncbi.nlm.nih.gov/41723581/

[4] Kim M, Seo M, Cho J, et al. Clinicopathologic variables according to disease severity in dogs with heartworm disease. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42152057/

[5] Stokowski S, Steuri SK, Lux C, et al. Gastric Dilatation and Volvulus and Heartworm Disease in a Dog With Situs Inversus. Vet Radiol Ultrasound. 2026. https://pubmed.ncbi.nlm.nih.gov/42011803/

[6] Glinšek Biškup U, Knap N, Korva M, et al. Molecular screening of mosquitoes for filarioid helminths in Slovenia. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42083038/

[7] Amarasinghe S, Ranasinghe K, Rodrigo W, et al. First molecular characterization of Dirofilaria vector species and the distribution of canine dirofilariasis in Gampaha district, Sri Lanka. Front Cell Infect Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42064220/

[8] Atkinson PJ, Nielsen TD, Caraguel C. Historical and Projected Impact of Global Climate Change on the Extrinsic Incubation of Dirofilaria immitis. Ecol Evol. 2025. https://pubmed.ncbi.nlm.nih.gov/41409073/

[9] Nakhale M, Hess JA, Oliver E, et al. Development of Dirofilaria immitis adult worms in NSG mice, detection of parasite-derived microRNA and comparative analysis of laboratory isolates. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/41617897/

[10] Power RI, Abdullah S, Walden HS, et al. Population genomics reveals an ancient origin of heartworms in canids. Commun Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41559308/

[11] Safdar I, Ur Rehman S, Roman U, et al. Serological and molecular detection of Dirofilaria immitis in pet dogs of Lahore, Pakistan. Ann Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41881496/

[12] Rajković M, Rajković V, Bogunović D. Dirofilaria immitis and Dirofilaria repens co-infection in a microfilaremic dog from Negotin, Eastern Serbia: Unusual localization of adult Dirofilaria repens in an abdominal hernia sac. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741045/

[13] Santiwattanatarm T, Sakcamduang W, Kongkaew C, et al. A systematic review and meta-analysis of non-arsenical adulticide protocols using moxidectin and doxycycline for the treatment of adult heartworm infection in dogs. Curr Res Parasitol Vector Borne Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42007372/

[14] Geary TG. Current issues in heartworm chemotherapy. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41851772/

[15] Nogueira LLDC, Araújo BVS, Antunes JMAP, et al. Blood bronchial mucus with Dirofilaria immitis adult worms after the treatment with doxycycline and moxidectin: a rare case presentation. Parasitology. 2026. https://pubmed.ncbi.nlm.nih.gov/41549761/

[16] Monteiro ACMP, Ribeiro CM, Fehlberg HF, et al. Emergence of Dirofilaria immitis in humid coastal zones: Epidemiological predictors and molecular characterization. Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41990946/

[17] Zanfagnini LG, Chocobar MLE, Schmidt EMS, et al. Unveiling filariid infections in dogs living in the Western Amazon, Brazil. Comp Immunol Microbiol Infect Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41818949/

[18] Nagy E, Nagy RR, Csivincsik Á, et al. Unusually low infection rate of Dirofilaria immitis in its wildlife hosts by the northern border of the Mediterranean climate zone in Hungary. Front Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41487481/

[19] Moreira SMK, Moreira AVC, Uquillas CAM, et al. Morpho-molecular identification of heartworms (Dirofilaria immitis) in domestic dogs in the Sucre canton, Ecuador. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41453721/

[20] Julca LA, Salas-Fajardo MY, Guevara S, et al. Seroprevalence of zoonotic vector-borne pathogens in domestic dogs from rural areas in northern Peru. Top Companion Anim Med. 2026. https://pubmed.ncbi.nlm.nih.gov/42035833/

[21] Vinnie-Siow WY, Tan TK, Sam SS, et al. Global prevalence, diagnostics and epidemiological trends of canine filariosis and associated zoonotic infections (2021-2025): a review. Vet Res Commun. 2025. https://pubmed.ncbi.nlm.nih.gov/41400797/

[22] Davis TA, Kelly MA, Sanders TL, et al. First molecular evidence for the presence of the canine heartworm, Dirofilaria immitis, on the island of Saipan, Northern Mariana Islands. Vet Parasitol Reg Stud Reports. 2025. https://pubmed.ncbi.nlm.nih.gov/41354525/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[23] Chocobar MLE, Eckersall DP, Panarese R, et al. Comparison of Haptoglobin Concentrations Between Microfilaremic and Amicrofilaremic Dogs Infected by Dirofilaria immitis. Vet Clin Pathol. 2026. https://pubmed.ncbi.nlm.nih.gov/41612543/

[24] Nonnis F, Corda A, Zeinoun P, et al. Feline heartworm disease in endemic settings: an integrated diagnostic approach. Res Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42225012/

[25] Atkinson PJ, Quimby C, Datt A, et al. Relative accuracy of point-of-care tests to rule-in heartworm infection in clinically suspected dogs using Bayesian latent class modelling. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41520422/

[26] Sanders TL, Starnes A, Kelly MA, et al. Comparative performance of the novel, point-of-care Pluslife Mini Dock Dirofilaria immitis/Dirofilaria repens detection test with the modified Knott's test in dogs. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42104384/

[27] Roya GM, Yagoob G, Bahram AT. Seasonal study of Blood Parasites: Dirofilaria immitis and Dipetalonema reconditum in the Guard Dogs of Tabriz city, Iran. Arch Razi Inst. 2025. https://pubmed.ncbi.nlm.nih.gov/41769291/

[28] Genc MG, Erol U, Sahin OF, et al. Application of COI-LAMP for Detection of Dirofilaria immitis with High Sensitivity and Specificity in Epidemiological Studies. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41801609/

[29] Kumar S, Lalicon IK, Prichard RK, et al. Development and evaluation of quadruplex droplet digital PCR assay for rapid detection of molecular markers associated with macrocyclic lactone resistance and susceptibility in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2026. https://pubmed.ncbi.nlm.nih.gov/41558254/

[30] Genchi M, Venco L, Fozzer M, et al. Efficacy and safety of a sustained-release formulation of ivermectin (FILAPREV) in preventing heartworm infection (Dirofilaria immitis) in dogs in two endemic areas of Italy. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42087229/

[31] Rodriguez J, Jones S, Mahabir S, et al. Comparative efficacy of six monthly doses of Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) versus NexGard Plus (afoxolaner, moxidectin, and pyrantel chewable tablets) against a macrocyclic lactone-resistant Dirofilaria immitis isolate in dogs. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42087216/

[32] Young L, Reinemeyer CR, Abdelmoneim M, et al. Efficacy of a novel chewable tablet (Credelio Quattro) containing lotilaner, moxidectin, praziquantel, and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41943128/

[33] Martínez-Durán D, Mujika M, Morales M, et al. Vector-borne pathogens in Spanish greyhounds from Central Spain: Prevalence and hematobiochemical findings. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741046/

[34] Nichols J, Forrester SG. Isolation and characterization of a novel glutamate-gated chloride channel subunit (GLC-2) from the canine heartworm Dirofilaria immitis. Mol Biochem Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41581768/

[35] Ranahewa DK, Dangolla A, Rajakaruna RS, et al. Subclinical Infections of Babesia and Dirofilaria in Dogs Presented to a Veterinary Teaching Hospital: Evidence for a Silent Reservoir of Infection in Sri Lanka. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42113286/